中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Volume 41 Issue 3
Mar.  2025
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2025  >  41(3): 580-587

Risk factors， diagnosis and treatment of perforation after endoscopic retrograde cholangiopancreatography

DOI: 10.12449/JCH250329

  • Department of Gastroenterology，The Second Affiliated Hospital of Kunming Medical University，Kunming 650101，China

More Information
  • Corresponding author: FU Yan， ky_fuyan@163.com （ORCID： 0000-0001-6955-0199）
  • Received Date: 2024-06-29
  • Accepted Date: 2024-08-08
  • Published Date: 2025-03-25
    Abstract
  • After 50 years of clinical development， endoscopic retrograde cholangiopancreatography （ERCP） has become the preferred method for the clinical diagnosis and treatment of cholangio-pancreatic duct diseases； however， the major postoperative complications of ERCP， such as pancreatitis， hemorrhage， and perforation， are still a difficult issue faced by clinicians， and postoperative perforation is associated with an extremely high risk of death. Therefore， it is very important to explore the risk factors for perforation after ERCP， make a definite diagnosis of perforation in a timely manner， and formulate precise prevention and treatment measures. By reviewing a large number of articles， this article summarizes the influencing factors for perforation after ERCP and related diagnosis and treatment measures.

     

    • FullText(HTML)
    • References(68)
  • [1]
    GUO SL, YANG X, HU HH, et al. Efficacy and safety of ERCP in minimally invasive treatment for biliary and pancreatic diseases[J/OL]. Chin ‍J ‍Hepatic Surg(Electronic Edition), ‍ 2023, ‍ 12( 2): ‍ 216- 220. DOI: 10.3877/cma.j.issn.2095-3232.2023.02.018.

    郭世龙, 杨潇, 胡欢欢, 等. ERCP在胆胰疾病微创治疗中的有效性及安全性[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12( 2): 216- 220. DOI: 10.3877/cma.j.issn.2095-3232.2023.02.018.
    [2]
    AK Ç, AYKUT H, PALA EM, et al. Post-ERCP complication analysis of an experienced center[J]. Surg Laparosc Endosc Percutan Tech, 2022, 32( 6): 707- 713. DOI: 10.1097/SLE.0000000000001113.
    [3]
    ERCP Group, Chinese Society of Digestive Endoscopology; Group Biliopancreatic, Chinese Association of Gastroenterologist and Hepatologist; National Clinical Research Center for Digestive Diseases. Chinese guidelines for ERCP(2018)[J]. Chin J Int Med, 2018, 57( 11): 772- 801. DOI: 10.3760/cma.j.issn.0578-1426.2018.11.002.

    中华医学会消化内镜学分会ERCP学组, 中国医师协会消化医师分会胆胰学组, 国家消化系统疾病临床医学研究中心. 中国ERCP指南(2018版)[J]. 中华内科杂志, ‍ 2018, ‍ 57( 11): ‍ 772- 801.‍ ‍ DOI: ‍10.3760/cma.j.issn.0578-1426.2018.11.002.
    [4]
    MACHADO NO. Management of duodenal perforation post-endoscopic retrograde cholangiopancreatography. When and whom to operate and what factors determine the outcome? A review article[J]. JOP, 2012, 13( 1): ‍‍ 18- 25.
    [5]
    ANDRIULLI A, LOPERFIDO S, NAPOLITANO G, et al. Incidence rates of post-ERCP ‍complications: ‍A ‍systematic survey of prospective ‍studies[J]. ‍ Am ‍J ‍Gastroenterol, ‍ 2007, ‍ 102( 8): ‍ 1781- 1788. ‍ DOI: ‍10.1111/j.1572-0241.2007.01279.x.
    [6]
    PASPATIS GA, DUMONCEAU JM, BARTHET M, et al. Diagnosis and management of iatrogenic endoscopic perforations: European society of gastrointestinal endoscopy(ESGE) position statement[J]. Endoscopy, 2014, 46( 8): 693- 711. DOI: 10.1055/s-0034-1377531.
    [7]
    POLITOVÁ P, DOUDA L, ŠTRINCL L, et al. Perforation of colon sigmoideum as a delayed complication of ERCP[J]. Gastroenterol Hepatol, 2022, 76( 6): 504- 507. DOI: 10.48095/ccgh2022504.
    [8]
    ENNS R, ELOUBEIDI MA, MERGENER K, et al. ERCP-related perforations: Risk factors and management[J]. Endoscopy, 2002, 34( 4): 293- 298. DOI: 10.1055/s-2002-23650.
    [9]
    KAYASHIMA H, IKEGAMI T, KASAGI Y, et al. Liver parenchyma perforation following endoscopic retrograde cholangiopancreatography[J]. Case Rep Gastroenterol, 2011, 5( 2): 487- 491. DOI: 10.1159/000331135.
    [10]
    NASIR UM, AHMED A, PANCHAL D, et al. Endoscopic retrograde cholangiopancreatography leading to pharyngeal perforation[J]. Case Rep Gastroenterol, 2020, 14( 1): 80- 86. DOI: 10.1159/000506182.
    [11]
    STAPFER M, SELBY RR, STAIN SC, et al. Management of duodenal perforation after endoscopic retrograde cholangiopancreatography and sphincterotomy[J]. ‍ Ann ‍Surg, ‍ 2000, ‍ 232( 2): ‍ 191- 198. ‍ DOI: ‍10.1097/00000658-200008000-00007.
    [12]
    CIROCCHI R, KELLY MD, GRIFFITHS EA, et al. A systematic review of the management and outcome of ERCP related duodenal perforations using a standardized classification system[J]. Surgeon, 2017, 15( 6): 379- 387. DOI: 10.1016/j.surge.2017.05.004.
    [13]
    COTTON PB, GARROW DA, GALLAGHER J, et al. Risk factors for complications after ERCP: A multivariate analysis of 11, 497 procedures over 12 years[J]. Gastrointest Endosc, 2009, 70( 1): ‍ 80- 88. ‍ DOI: 10.1016/j.gie.2008.10.039.
    [14]
    Endoscopic Surgery Group, Digestive Endoscopy Branch, Chinese Medical Association; Endoscopic Surgery Expert Working Group, Chinese College of Surgeons; Professional Committee of Pancreatic Disease, Chinese Medical Doctor Association. Guideline for the management of complications of duodenal perforation associated with ERCP in China(2023 edition)[J]. Chin J Dig Surg, 2024, 23( 1): 1- 9. DOI: 10.3760/cma.j.cn115610-20231025-00166.

    中华医学会消化内镜学分会内镜外科学组, 中国医师协会外科医师分会内镜外科专家工作组, 中国医师协会胰腺病专业委员会. 中国ERCP致十二指肠穿孔并发症管理指南(2023版)[J]. 中华消化外科杂志, 2024, 23( 1): 1- 9. DOI: 10.3760/cma.j.cn115610-20231025-00166.
    [15]
    KATSINELOS P, LAZARAKI G, CHATZIMAVROUDIS G, et al. Risk factors for therapeutic ERCP-related complications: An analysis of 2, 715 cases performed by a single endoscopist[J]. Ann Gastroenterol, 2014, 27( 1): 65- 72.
    [16]
    NAVANEETHAN U, KONJETI R, LOURDUSAMY V, et al. Precut sphincterotomy: Efficacy for ductal access and the risk of adverse events[J]. Gastrointest Endosc, 2015, 81( 4): 924- 931. DOI: 10.1016/j.gie.2014.09.015.
    [17]
    LANGERTH A, ISAKSSON B, KARLSON BM, et al. ERCP-related perforations: A population-based study of incidence, mortality, and risk factors[J]. Surg Endosc, 2020, 34( 5): ‍ 1939- 1947. DOI: ‍10.1007/s00464-019-06966-w.
    [18]
    WEISER R, PENCOVICH N, MLYNARSKY L, et al. Management of endoscopic retrograde cholangiopancreatography-related perforations: Experience of a tertiary center[J]. Surgery, 2017, 161( 4): 920- 929. DOI: 10.1016/j.surg.2016.10.029.
    [19]
    BENSON ME, BYRNE S, BRUST DJ, et al. EUS and ERCP complication rates are not increased in elderly patients[J]. Dig Dis Sci, 2010, 55( 11): 3278- 3283. DOI: 10.1007/s10620-010-1152-2.
    [20]
    TAKANO S, FUKASAWA M, SHINDO H, et al. Risk factors for perforation during endoscopic retrograde cholangiopancreatography in post-reconstruction intestinal tract[J]. World J Clin Cases, 2019, 7( 1): 10- 18. DOI: 10.12998/wjcc.v7.i1.10.
    [21]
    CHENG CL, LIU NJ, TANG JH, et al. Double-balloon enteroscopy for ERCP in patients with billroth II anatomy: Results of a large series of papillary large-balloon dilation for biliary stone removal[J]. Endosc Int Open, 2015, 3( 3): E216- E222. DOI: 10.1055/s-0034-1391480.
    [22]
    LICHTENSTEIN DR. Post-surgical anatomy and ERCP[J]. Tech Gastrointest Endosc, 2007, 9( 2): ‍ 114- 124.
    [23]
    WU WG, ZHANG WJ, GU J, et al. Retrieval-balloon-assisted enterography for ERCP after Billroth II gastroenterostomy and Braun anastomosis[J]. World J Gastroenterol, 2014, 20( 31): ‍ 1 0921- 10926. DOI: 10.3748/wjg.v20.i31.10921.
    [24]
    NI JB, ZHU MY, LI K, et al. The feasibility of cap-assisted routine adult colonoscope for therapeutic endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y reconstruction after total gastrectomy[J]. J Dig Dis, 2021, 22( 12): 721- 726. DOI: 10.1111/1751-2980.13069.
    [25]
    MU PL, YUE P, LI FW, et al. Does periampullary diverticulum affect ERCP cannulation and post-procedure complications? An up-to-date meta-analysis[J]. Turk J Gastroenterol, 2020, 31( 3): ‍ 193- 204. DOI: 10.5152/tjg.2020.19058.
    [26]
    KARAAHMET F, KEKILLI M. The presence of periampullary diverticulum increased the complications of endoscopic retrograde cholangiopancreatography[J]. Eur J Gastroenterol Hepatol, ‍ 2018, ‍ 30( 9): 1009- 1012. DOI: 10.1097/MEG.0000000000001172.
    [27]
    JAYARAJ M, MOHAN BP, DHINDSA BS, et al. Periampullary diverticula and ERCP outcomes: A systematic review and meta-analysis[J]. Dig Dis Sci, 2019, 64( 5): 1364- 1376. DOI: 10.1007/s10620-018-5314-y.
    [28]
    SFARTI VC, BĂLAN G Jr, AŞ CHIRIAC, et al. Endoscopic retrograde cholangiopancreatography(ERCP) in patients with periampullary diverticula[J]. Rom J Morphol Embryol, 2018, 59( 3): 833- 837.
    [29]
    YUE P, WANG ZY, ZHANG LD, et al. Clinical characteristics of choledocholithiasis combined with periampullary diverticulum and influencing factor analysis for difficult cannulation of endoscopic retrograde cholangiopan-creatography: a report of 1 920 cases[J]. Chin J Dig Surg, 2023, 22( 1): 113- 121. DOI: 10.3760/cma.j.cn115610-20221201-00723.

    岳平, 王震宇, 张雷达, 等. 胆总管结石合并壶腹周围憩室临床特征急行ERCP发生困难插管的影响因素分析(附1 920例报告)[J]. 中华消化外科杂志, 2023, 22( 1): 113- 121. DOI: 10.3760/cma.j.cn115610-20221201-00723.
    [30]
    SHI HX, YE YQ, ZHAO HW, et al. A new classification of periampullary diverticulum: Cannulation of papilla on the inner margins of the diverticulum(type IIa) is more challenging[J]. BMC Gastroenterol, 2023, 23( 1): 252. DOI: 10.1186/s12876-023-02862-9.
    [31]
    PARK TY, SONG TJ. Recent advances in endoscopic retrograde cholangiopancreatography in billroth II gastrectomy patients: A systematic review[J]. World J Gastroenterol, 2019, 25( 24): ‍ 3091- 3107.‍ DOI: 10.3748/wjg.v25.i24.3091.
    [32]
    KIM GH, KANG DH, SONG GA, et al. Endoscopic removal of bile-duct stones by using a rotatable papillotome and a large-balloon dilator in patients with a Billroth II gastrectomy(with video)[J]. Gastrointest Endosc, 2008, 67( 7): 1134- 1138. DOI: 10.1016/j.gie.2007.12.016.
    [33]
    JANG HW, LEE KJ, JUNG MJ, et al. Endoscopic papillary large balloon dilatation alone is safe and effective for the treatment of difficult choledocholithiasis in cases of billroth II gastrectomy: A single center experience[J]. Dig Dis Sci, 2013, 58( 6): 1737- 1743. DOI: 10.1007/s10620-013-2580-6.
    [34]
    NAVANEETHAN U, KONJETI R, VENKATESH PG, et al. Early precut sphincterotomy and the risk of endoscopic retrograde cholangiopancreatography related complications: An updated meta-analysis[J]. World J Gastrointest Endosc, 2014, 6( 5): 200- 208. DOI: 10.4253/wjge.v6.i5.200.
    [35]
    MANES G, di GIORGIO P, REPICI A, et al. An analysis of the factors associated with the development of complications in patients undergoing precut sphincterotomy: ‍A prospective, controlled, randomized, multicenter study[J]. Am J Gastroenterol, 2009, 104( 10): 2412- 2417. DOI: 10.1038/ajg.2009.345.
    [36]
    PARK SJ, KIM JH, HWANG JC, et al. Factors predictive of adverse events following endoscopic papillary large balloon dilation: Results from a multicenter series[J]. Dig Dis Sci, 2013, 58( 4): ‍ 1100- 1109. DOI: 10.1007/s10620-012-2494-8.
    [37]
    DUMONCEAU JM, KAPRAL C, AABAKKEN L, et al. ERCP-related adverse events: European society of gastrointestinal endoscopy(ESGE) guideline[J]. Endoscopy, 2020, 52( 2): 127- 149. DOI: 10.1055/a-1075-4080.
    [38]
    SHIM CS, KIM JW, LEE TY, et al. Is endoscopic papillary large balloon dilation safe for treating large CBD stones?[J]. Saudi J Gastroenterol, 2016, 22( 4): 251- 259. DOI: 10.4103/1319-3767.187599.
    [39]
    YAMAUCHI H, IWAI T, OKUWAKI K, et al. Risk factors for perforation during endoscopic papillary large balloon dilation and bile duct stone removal[J]. Dig Dis Sci, 2022, 67( 5): 1890- 1900.‍ DOI: ‍10.1007/s10620-021-06974-8.
    [40]
    KAMADA H, KOBARA H, YAMANA H, et al. Repeated balloon inflation under low pressure may reduce serious adverse events during endoscopic papillary large balloon dilation[J]. ‍ J ‍Hepatobiliary Pancreat Sci, 2022, 29( 5): e33- e35. DOI: 10.1002/jhbp.987.
    [41]
    FATIMA J, BARON TH, TOPAZIAN MD, et al. Pancreaticobiliary and duodenal perforations after periampullary endoscopic procedures: Diagnosis and management[J]. Arch Surg, 2007, 142( 5): 448-454; discussion 454-455. DOI: 10.1001/archsurg.142.5.448.
    [42]
    IDA BB. A rare clinical presentation of third part duodenal perforation due to post-endoscopic retrograde cholangiopancreatography stent migration on advanced stage peri-ampullary tumor[J]. JGH Open, 2021, 5( 8): 968- 970. DOI: 10.1002/jgh3.12608.
    [43]
    TIRELLI F, MIRCO P, FRANSVEA P, et al. Perforation due to biliary stent: Case report and review[J]. Dig Dis Interv, 2021, 5( 4): 324- 330. DOI: 10.1055/s-0041-1733777.
    [44]
    GANDHI JA, SHINDE PH, NAGUR BK, et al. Endoscopic retrograde cholangiopancreatography scope-induced duodenojejunal flexure perforation: The world‍‍’‍‍‍s first case[J]. J Dig Endosc, 2017, 8( 3): 145- 147. DOI: 10.4103/jde.jde_87_16.
    [45]
    BILL JG, SMITH Z, BRANCHECK J, et al. The importance of early recognition in management of ERCP-related perforations[J]. ‍ Surg Endosc, 2018, 32( 12): 4841- 4849. DOI: 10.1007/s00464-018-6235-8.
    [46]
    BORAZAN E, KONDUK BT. Comparison of early and delayed diagnosis of mortality in ERCP perforations: A high-volume patient experience[J]. Ulus Travma Acil Cerrahi Derg, 2020, 26( 5): ‍ 746- 753. ‍ DOI: 10.14744/tjtes.2020.61289.
    [47]
    CHANDRASEKHARA V, KHASHAB MA, MUTHUSAMY VR, et al. Adverse events associated with ERCP[J]. Gastrointest Endosc, 2017, 85( 1): 32- 47. DOI: 10.1016/j.gie.2016.06.051.
    [48]
    MANOHARAN D, SRIVASTAVA DN, GUPTA AK, et al. Complications of endoscopic retrograde cholangiopancreatography: An imaging review[J]. Abdom Radiol(NY), 2019, 44( 6): 2205- 2216. DOI: 10.1007/s00261-019-01953-0.
    [49]
    WU HM, DIXON E, MAY GR, et al. Management of perforation after endoscopic retrograde cholangiopancreatography(ERCP): A population-based review[J]. HPB(Oxford), 2006, 8( 5): 393- 399. DOI: 10.1080/13651820600700617.
    [50]
    AVGERINOS DV, LLAGUNA OH, LO AY, et al. Management of endoscopic retrograde cholangiopancreatography: Related duodenal perforations[J]. Surg Endosc, 2009, 23( 4): 833- 838. DOI: 10.1007/s00464-008-0157-9.
    [51]
    SHIMIZU T, YOSHIOKA M, MATSUSHITA A, et al. Causes and management of endoscopic retrograde cholangiopancreatography-related perforation: A retrospective study[J]. J Nippon Med Sch, 2023, 90( 4): 316- 325. DOI: 10.1272/jnms.JNMS.2023_90-305.
    [52]
    GENZLINGER JL, MCPHEE MS, FISHER JK, et al. Significance of retroperitoneal air after endoscopic retrograde cholangiopancreatography with sphincterotomy[J]. Am J Gastroenterol, 1999, 94( 5): ‍ 1267- 1270. DOI: 10.1111/j.1572-0241.1999.00996.x.
    [53]
    TASAR P, KILICTURGAY SA. Early results of conservative and surgical approach in Endoscopic Retrograde Cholangiopancreatography(ERCP) Perforations Single center experience[J]. Ann Ital Chir, 2023, 94: 367- 374.
    [54]
    PASPATIS GA, ARVANITAKIS M, DUMONCEAU JM, et al. Diagnosis and management of iatrogenic endoscopic perforations: European society of gastrointestinal endoscopy(ESGE) position statement-update 2020[J]. Endoscopy, 2020, 52( 9): 792- 810. DOI: 10.1055/a-1222-3191.
    [55]
    ODEMIS B, OZTAS E, KUZU UB, et al. Can a fully covered self-expandable metallic stent be used temporarily for the management of duodenal retroperitoneal perforation during ERCP as a part of conservative therapy?[J]. Surg Laparosc Endosc Percutan Tech, 2016, 26( 1): e9- e17. DOI: 10.1097/SLE.0000000000000240.
    [56]
    TAVUSBAY C, ALPER E, GÖKOVA M, et al. Management of perforation after endoscopic retrograde cholangiopancreatography[J]. Ulus Travma Acil Cerrahi Derg, 2016, 22( 5): ‍ 441- 448. ‍ DOI: ‍10.5505/tjtes.2016.42247.
    [57]
    ZHU GY, HU FL, WANG CM. Recent advances in prevention and management of endoscopic retrograde cholangiopancreatography-related duodenal perforation[J]. Wideochir Inne Tech Maloinwazyjne, 2021, 16( 1): 19- 29. DOI: 10.5114/wiitm.2020.101025.
    [58]
    JIMÉNEZ CUBEDO E, LÓPEZ MONCLÚS J, LUCENA DE LA POZA JL, et al. Review of duodenal perforations after endoscopic retrograde cholangiopancreatography in Hospital Puerta de Hierro from 1999 to 2014[J]. Rev Esp Enferm Dig, 2018, 110( 8): 515- 519. DOI: 10.17235/reed.2018.5255/2017.
    [59]
    KIM K, KIM EB, CHOI YH, et al. Repair of an endoscopic retrograde cholangiopancreatography-related large duodenal perforation using double endoscopic band ligation and endoclipping[J]. Clin Endosc, 2017, 50( 2): 202- 205. DOI: 10.5946/ce.2016.112.
    [60]
    MIAO YS, LI YY, CHENG BW, et al. Clinical analysis of 45 cases of perforation were identified during endoscopic retrograde cholangiopancreatography procedure[J]. Front Med(Lausanne), 2022, 9: 1039954. DOI: 10.3389/fmed.2022.1039954.
    [61]
    SHI D, YANG JF, LIU YP. Endoscopic treatment of endoscopic retrograde cholangiopancreatography-related duodenal perforations[J]. J Laparoendosc Adv Surg Tech A, 2019, 29( 3): 385- 391. DOI: 10.1089/lap.2018.0617.
    [62]
    LEE JH, KEDIA P, STAVROPOULOS SN, et al. AGA clinical practice update on endoscopic management of perforations in gastrointestinal tract: Expert review[J]. Clin Gastroenterol Hepatol, 2021, 19( 11): 2252- 2261. e 2. DOI: 10.1016/j.cgh.2021.06.045.
    [63]
    TRINGALI A, CINTOLO M, HASSAN C, et al. Type II-III ERCP-related perforations treated with temporary Fully covered self-expandable stents[J]. ‍ Dig ‍Liver ‍Dis, ‍ 2017, ‍ 49( 10): ‍ 1169- 1170. ‍ DOI: ‍10.1016/j.dld.2017.06.005.
    [64]
    TRINGALI A, PIZZICANNELLA M, ANDRISANI G, et al. Temporary FC-SEMS for type II ERCP-related perforations: A case series from two referral centers and review of the literature[J]. Scand J Gastroenterol, 2018, 53( 6): 760- 767. DOI: 10.1080/00365521.2018.1458894.
    [65]
    BOZBIYIK O, CETIN B, GUMUS T, et al. Fully covered self-expandable metal stent for intraprocedural or late-diagnosed Type-II endoscopic retrograde cholangiopancreatography-related perforations[J]. ‍ BMC Gastroenterol, 2022, 22( 1): 385. DOI: 10.1186/s12876-022-02466-9.
    [66]
    THEOPISTOS V, THEOCHARIS G, KONSTANTAKIS C, et al. Non-operative management of type 2 ERCP-related retroperitoneal duodenal perforations: A 9-year experience from a single center[J]. Gastroenterology Res, 2018, 11( 3): 207- 212. DOI: 10.14740/gr1007w.
    [67]
    SAKAMOTO J, OGURA T, UENO S, et al. Evaluation of exclusive internal endoscopic drainage for complex biloma with transluminal and transpapillary stenting[J]. Endosc Int Open, 2024, 12( 2): e262- e268. DOI: 10.1055/a-2261-3137.
    [68]
    ŞENOCAK R, COŞKUN AK, KAYMAK Ş, et al. Successful conservative treatment of type 3 injury(ductal injury) developing after ERCP[J]. Arab J Gastroenterol, ‍ 2018, 19( 2): ‍ 88- 90. ‍ DOI: ‍10.1016/j.ajg.2018.02.005.
    • Relative Articles

  • Relative Articles

    [1]Yuxin WANG, Weigang GU, Zheng JIN, Xiaofeng ZHANG. Successful treatment of biliary fistula after Beger surgery by oral choledochoscopy-assisted percutaneous-endoscopic rendezvous technique： A case report[J]. Journal of Clinical Hepatology, 2025, 41(2): 333-336. doi: 10.12449/JCH250220
    [2]Di WU, Dahua DAI, Wenmei LIANG, Bao FU, Xiaoyun FU. Clinical features of acute pancreatitis in pregnancy and related risk factors[J]. Journal of Clinical Hepatology, 2024, 40(5): 1009-1015. doi: 10.12449/JCH240522
    [3]Chunyan MENG, Jing WANG, Bo WANG. Advances in the differential diagnosis of malignant bile duct stenosis[J]. Journal of Clinical Hepatology, 2024, 40(4): 844-849. doi: 10.12449/JCH240433
    [4]Liying TAO, Hongguang WANG, Qingmei GUO, Lianyu PIAO, Xiang GUO, Libin RUAN, Shizhu LIU, Zhen SUN. Efficacy of endoscopic retrograde cholangiopancreatography combined with electrohydraulic lithotripsy under the direct view of eyeMax biliary-pancreatic imaging system in treatment of difficult choledocholithiasis[J]. Journal of Clinical Hepatology, 2024, 40(2): 351-355. doi: 10.12449/JCH240220
    [5]Yi LE, Hao YANG, Hu LIU, Zhaoyang CUI, Xiangning ZHAO, Liang AN, Haizhu LI, Shaogeng ZHANG. Advances in the diagnosis and treatment of gallbladder carcinoma[J]. Journal of Clinical Hepatology, 2023, 39(11): 2738-2744. doi: 10.3969/j.issn.1001-5256.2023.11.032
    [6]Ling FAN, Yan FU, Yi LIU, Hua HUANG, Jing NI, Juan TANG. Research advances in hemorrhage after endoscopic retrograde cholangiopancreatography[J]. Journal of Clinical Hepatology, 2023, 39(10): 2497-2505. doi: 10.3969/j.issn.1001-5256.2023.10.032
    [7]Yu LIANG, Yuanhong ZHAO, Zheng LI. Recent advancement in research on intrahepatic cholangiocarcinoma: Risk factors and pathogenesis[J]. Journal of Clinical Hepatology, 2022, 38(10): 2391-2395. doi: 10.3969/j.issn.1001-5256.2022.10.037
    [8]Jiali MA, Yu JIANG, Julong HU, Zhenglin AI, Lingling HE, Yuling ZHOU, Xiuxia LIANG, Yijun LIN, Hongshan WEI, Ping LI. Risk factors for rebleeding after endoscopic selective variceal devascularization in patients with hepatitis B cirrhosis and acute variceal bleeding[J]. Journal of Clinical Hepatology, 2021, 37(11): 2569-2574. doi: 10.3969/j.issn.1001-5256.2021.11.017
    [9]Yuling DUAN, Zanjie FENG, Guoxin FAN, Lei WANG, Kangwei LIU, Cijun PENG. Risk factors for open pancreatic necrosectomy in patients with severe acute pancreatitis: An analysis based on the surgical step-up approach[J]. Journal of Clinical Hepatology, 2021, 37(4): 893-897. doi: 10.3969/j.issn.1001-5256.2021.04.033
    [10]Wang CaiBin, Su Yang. Risk factors for posthepatectomy liver failure and related prevention and treatment methods[J]. Journal of Clinical Hepatology, 2020, 36(9): 2119-2124. doi: 10.3969/j.issn.1001-5256.2020.09.048
    [11]LI ZhengHong, DONG YuWei, LU LunGen. Risk factors,diagnosis,and updated classification of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2020, 36(11): 2411-2414. doi: 10.3969/j.issn.1001-5256.2020.11.003
    [12]Wang Lu, Han Ying. An excerpt of British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis (2019)[J]. Journal of Clinical Hepatology, 2019, 35(9): 1937-1941. doi: 10.3969/j.issn.1001-5256.2019.09.010
    [13]Chen ShanPeng, Wang ZhiXiang, Zhang XiaoDi, Shen NaiYing, Wei ZhiLi. Epidemiology of polypoid lesions of the gallbladder and related risk factors[J]. Journal of Clinical Hepatology, 2019, 35(2): 441-443. doi: 10.3969/j.issn.1001-5256.2019.02.045
    [14]Wang RongFeng, Lu: Yi, Zhang XiaoGang. Advances in the diagnosis and treatment of severe acute cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(12): 2622-2626. doi: 10.3969/j.issn.1001-5256.2019.12.002
    [15]Wang ChunQiu, Ma YingCai, Zhu ZhiYong, Yuan Ling. Risk factors for recurrence of common bile duct stones after endoscopic retrograde cholangiopancreatography[J]. Journal of Clinical Hepatology, 2017, 33(2): 297-299. doi: 10.3969/j.issn.1001-5256.2017.02.019
    [16]YIERPAN Aishan, Gao Feng. Risk factors for hyperamylasemia after endoscopic retrograde cholangiopancreatography[J]. Journal of Clinical Hepatology, 2016, 32(1): 119-122. doi: 10.3969/j.issn.1001-5256.2016.01.022
    [17]Bi RongXin, Guo QuanZhou, Xue ZhiGuang, Hou ZhiQiang. Analysis of incidence and risk factors for ERCP-related adverse events in patients with primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2015, 31(2): 189-192. doi: 10.3969/j.issn.1001-5256.2015.02.011
    [18]Gu Chuan, Li Lu, Wang Jun, Hou FengQin, Xu XiaoYuan. Study on efficacy of endoscopic ligation therapy for esophageal varices and risk factors for postoperative rebleeding[J]. Journal of Clinical Hepatology, 2014, 30(12): 1279-1282. doi: 10.3969/j.issn.1001-5256.2014.12.011
    [19]Yu Zheng, Jia JiDong. Risk factors, diagnostic criteria, and drug discontinuation criteria for drug- induced liver injury[J]. Journal of Clinical Hepatology, 2013, 29(9): 674-677. doi: 10.3969/j.issn.1001-5256.2013.09.010
    [20]Zhu YongXiang, Fan JianGao, Li Rui, Li XinJian. Prevalence of cholelithiasis and associated risk factors among adult population in Shanghai[J]. Journal of Clinical Hepatology, 2010, 26(6): 646-650.
    • Supplements(0)
    • Cited By
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 26.7 %FULLTEXT: 26.7 %META: 65.3 %META: 65.3 %PDF: 8.0 %PDF: 8.0 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution北京: 2.7 %北京: 2.7 %南宁: 1.3 %南宁: 1.3 %哥伦布: 1.3 %哥伦布: 1.3 %太原: 4.0 %太原: 4.0 %张家口: 18.7 %张家口: 18.7 %杭州: 1.3 %杭州: 1.3 %石家庄: 5.3 %石家庄: 5.3 %纽约州: 1.3 %纽约州: 1.3 %芒廷维尤: 30.7 %芒廷维尤: 30.7 %芝加哥: 5.3 %芝加哥: 5.3 %苏州: 1.3 %苏州: 1.3 %西宁: 8.0 %西宁: 8.0 %诺沃克: 1.3 %诺沃克: 1.3 %赣州: 1.3 %赣州: 1.3 %赤峰: 2.7 %赤峰: 2.7 %运城: 1.3 %运城: 1.3 %长春: 12.0 %长春: 12.0 %北京南宁哥伦布太原张家口杭州石家庄纽约州芒廷维尤芝加哥苏州西宁诺沃克赣州赤峰运城长春

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (48) PDF downloads(6) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[1878]YesterdayPV[3517]TodayIP[615]TodayPV[916]Online[32]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return